drugset / Trial / NCT01722318
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study in patients with IBS-C.
Timeline
- Start
- 2012-11
- Primary completion
- 2014-04
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Plecanatide | Peptide | 0.3 mg | Oral |
| Comparator | Plecanatide | Peptide | 1 mg | Oral |
| Comparator | Plecanatide | Peptide | 3 mg | Oral |
| Comparator | Plecanatide | Peptide | 9 mg | Oral |